A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of Isolated MEDiastinal lymphadenopathY (REMEDY)
Although the literature is replete with data on the utility of Endobronchial Ultrasound for
lung cancer, there are very few data available on its role in the diagnosis of isolated
mediastinal lymphadenopathy due to other causes such as sarcoid, tuberculosis or lymphoma.
The REMEDY trial aims to evaluate the accuracy of EBUS in this setting and assess any
reduction in the number of mediastinoscopies and healthcare costs.
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Number of mediastinoscopies prevented and healthcare costs
Sam Janes, MD PhD
University College, London
United Kingdom: Research Ethics Committee